[go: up one dir, main page]

JP5653291B2 - Sealed brachytherapy container - Google Patents

Sealed brachytherapy container Download PDF

Info

Publication number
JP5653291B2
JP5653291B2 JP2011108769A JP2011108769A JP5653291B2 JP 5653291 B2 JP5653291 B2 JP 5653291B2 JP 2011108769 A JP2011108769 A JP 2011108769A JP 2011108769 A JP2011108769 A JP 2011108769A JP 5653291 B2 JP5653291 B2 JP 5653291B2
Authority
JP
Japan
Prior art keywords
container
brachytherapy
sealed
source
lid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011108769A
Other languages
Japanese (ja)
Other versions
JP2012230093A (en
Inventor
正二 高橋
正二 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
NMP Business Support Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
NMP Business Support Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd, NMP Business Support Co Ltd filed Critical Nihon Medi Physics Co Ltd
Priority to JP2011108769A priority Critical patent/JP5653291B2/en
Publication of JP2012230093A publication Critical patent/JP2012230093A/en
Application granted granted Critical
Publication of JP5653291B2 publication Critical patent/JP5653291B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

本発明は、密封小線源収容容器に関するものである。更に詳しくは、本発明は、125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器であって、容器外への放射線の漏洩を防止し、かつ鉛に起因する環境汚染問題を軽減又は解消でき、しかも製造時の加工性に優れるという特徴を有する密封小線源収容容器に関するものである。The present invention relates to a sealed brachytherapy container. More particularly, the present invention relates to a container for containing a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source, preventing leakage of radiation to the outside of the container, and lead. The present invention relates to a sealed brachytherapy container that can reduce or eliminate the environmental pollution problem caused by the above-mentioned characteristics and that is excellent in workability during manufacturing.

がんの治療法のひとつとして密封小線源療法がある。これは、放射線を放出する密封小線源をがん病巣部分及び/又はがん病巣周辺部分に埋め込み、密封小線源から放出される放射線をがん病巣部分に照射することにより、がん細胞を壊滅させる治療法である。密封小線源療法は、特に前立腺がんの治療に汎用されている(「前立腺がんブラキセラピー」と呼ばれる。)(たとえば、非特許文献1参照。)。この場合、密封小線源(「シード」とも言う。)としては、長さ数ミリメートルで直径1ミリメートル程度の円柱形のチタン製のカプセル内に、銀製の短線に化学的に結合された放射線源である125I又は103Pdが密封されたものが用いられるのが一般である。密封小線源は、通常50〜100個程度が、前立腺のがん病巣部分及び/又はがん病巣周辺部分に埋め込まれ、いったん埋め込まれた密封小線源は、原則としてそのまま永久に体内に留め置かれる。One of the cancer treatments is brachytherapy. This is because cancer brachytherapy is performed by implanting a brachytherapy source that emits radiation in the cancer lesion area and / or the surrounding area of the cancer lesion and irradiating the cancer lesion area with radiation emitted from the brachytherapy source. It is a cure that destroys The brachytherapy is widely used particularly for the treatment of prostate cancer (referred to as “prostate cancer brachytherapy”) (for example, see Non-Patent Document 1). In this case, the hermetically brazed beam source (also referred to as “seed”) is a radiation source chemically bonded to a silver short wire in a cylindrical titanium capsule having a length of several millimeters and a diameter of about 1 millimeter. In general, a sealed material of 125 I or 103 Pd is used. About 50 to 100 sealed brachytherapy sources are usually implanted in the cancer lesion part of the prostate and / or the peripheral part of the cancer lesion. Placed.

ところで、密封小線源は放射線を放出するものであり、非使用時には放射線を遮蔽する能力を有する容器に収容して保管する必要がある。放射線を遮蔽する能力を有する容器としては、放射線の遮蔽材として知られる鉛が用いられたものが一般である(特許文献1及び特許文献2参照)。  By the way, the sealed braid source emits radiation, and it is necessary to store and store it in a container having the ability to shield radiation when not in use. As a container having the ability to shield radiation, a container using lead known as a radiation shielding material is generally used (see Patent Document 1 and Patent Document 2).

また、鉛以外の材料を用いた例として、ステンレスを用いた密封小線源の遮蔽材が開示されている(非特許文献2、非特許文献3)。  Further, as an example using a material other than lead, a shielding material for a sealed small wire source using stainless steel is disclosed (Non-patent Documents 2 and 3).

特表2008−540042号公報Special table 2008-540042 gazette 特開2004−151117号公報JP 2004-151117 A

日本メジフィジック株式会社「前立腺がんの小線源療法」[平成23年2月16日検索]、インターネット<URL:http://www.nmp.co.jp/seed/about/brachytherapy.html>Nippon Mediphysics Co., Ltd. “Breast Source Therapy for Prostate Cancer” [searched on February 16, 2011], Internet <URL: http: // www. nmp. co. jp / seed / about / brachytherapy. html> ”ONCURA RAPID Strand▲TM▼ Instructions for the use of Rapid Strand for Interstitial Brachytherapy Treatments”,[online],p.6,[平成23年4月13日検索]、インターネット<URL:http://www.oncura.net/media/pdf/RAPID−SPC.pdf>"ONCURA RAPID Strand ™ TM Instructions for the use of Rapid Strand for Intertension Brachytherapy Treatments", [online], p. 6, [Search on April 13, 2011], Internet <URL: http: // www. oncura. net / media / pdf / RAPID-SPC. pdf> 株式会社メディコン、シードアプリケーター添付文書、[online]、[平成23年4月13日検索]、インターネット<http://www.info.pmda.go.jp/downfiles/md/PDF/780045_27B1X00052000103_B_04_04.pdf>Medicon Inc., Seed Applicator Attachment, [online], [April 13, 2011 Search], Internet <http: // www. info. pmda. go. jp / downfiles / md / PDF / 780045_27B1X00052000103_B_04_04. pdf>

ところが、鉛は放射線の遮蔽効果には優れるものの、廃棄された場合、鉛により環境を汚染するという問題(鉛害問題)が発生する。タングステンやステンレスを用いると、上記の様な鉛による環境問題は回避できるものの、一般にこれらの材料は機械加工が必要となり、加工費が高くなる上、量産した場合であっても加工費自体は下がらないため、全体としてのコスト増は避けられないといった欠点がある。また、タングステンについては、材料そのものが高価であるといった欠点も有している。  However, although lead has an excellent radiation shielding effect, when it is discarded, there is a problem that the environment is contaminated with lead (lead damage problem). When tungsten or stainless steel is used, environmental problems due to lead as described above can be avoided. However, these materials generally require machining, which increases processing costs and reduces the processing costs even when mass-produced. Therefore, there is a disadvantage that the increase in cost as a whole is inevitable. Tungsten also has a drawback that the material itself is expensive.

かかる状況において、本発明が解決しようとする課題は、125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器であって、容器外への放射線の漏洩を防止し、かつ鉛に起因する環境汚染問題を軽減又は解消でき、しかも製造時の加工性に優れるという特徴を有する密封小線源収容容器を提供する点にある。In such a situation, the problem to be solved by the present invention is a container containing a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source, and leakage of radiation to the outside of the container It is an object of the present invention to provide a hermetically sealed brachytherapy container that can prevent the environmental pollution caused by lead and can reduce or eliminate the problem of environmental pollution caused by lead and that is excellent in workability during manufacture.

すなわち、本発明は、125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器であって、容器の全面が放射線の遮蔽材からなり、該遮蔽材の少なくとも一部が亜鉛及び/又は亜鉛合金である密封小線源収容容器に係るものである。That is, the present invention is a container that houses a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source, and the entire surface of the container is made of a radiation shielding material. It relates to a sealed brachytherapy container that is at least partially zinc and / or zinc alloy.

従来、放射線を遮蔽する物質としては、鉛又はタングステンを用いることが一般的であり、それ以外の物質では十分な遮蔽効果が得られないため、遮蔽材としては用いられないと考えるのが技術常識であった。鉛、タングステン以外の材料としては、まれに、ステンレスを利用した例が開示されているに過ぎなかった。我々はこのような技術常識に反し、密封小線源、特に体内から脱落した密封小線源に対しては、成型加工が可能であり、加工性に優れる亜鉛又は亜鉛合金であっても十分な遮蔽効果を得ることができ、遮蔽材として用いることが可能であることを見出し、本発明を完成させたものである。  Conventionally, lead or tungsten is generally used as a material that shields radiation, and other materials cannot provide a sufficient shielding effect. Therefore, it is common knowledge that it is not used as a shielding material. Met. As materials other than lead and tungsten, an example using stainless steel is rarely disclosed. Contrary to such common technical knowledge, we can mold the brachywire source, especially the brachytherapy source that has fallen out of the body, and even zinc or zinc alloy with excellent processability is sufficient. It has been found that a shielding effect can be obtained and can be used as a shielding material, and the present invention has been completed.

本発明により、125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器であって、容器外への放射線の漏洩を防止し、かつ鉛に起因する環境汚染問題を軽減又は解消でき、しかも製造時の加工性に優れるという特徴を有する密封小線源収容容器を提供することができる。According to the present invention, a container for containing a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source, preventing leakage of radiation to the outside of the container, and an environment caused by lead It is possible to provide a sealed brachytherapy container that can reduce or eliminate the contamination problem and has excellent characteristics of processability during production.

本発明の密封小線源収容容器の実施態様の例を示す図である。It is a figure which shows the example of the embodiment of the sealed braid source storage container of this invention. 実施例1で用いた本発明の密封小線源収容容器を示す図である。It is a figure which shows the sealed brachytherapy container of this invention used in Example 1. FIG. 実施例2における表面線量率を示す図である。It is a figure which shows the surface dose rate in Example 2. FIG.

以下、本発明の実施の形態について、詳細に説明する。  Hereinafter, embodiments of the present invention will be described in detail.

本発明の容器は、125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器である。The container of the present invention is a container for containing a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source.

密封小線源療法とは、前記のとおりであり、放射線を放出する密封小線源をがん病巣部分及び/又はがん病巣周辺部分に埋め込み、密封小線源から放出される放射線をがん病巣部分に照射することにより、がん細胞を壊滅させる治療法である。  The brachytherapy is as described above, and a brachytherapy source that emits radiation is embedded in a cancer lesion portion and / or a peripheral portion of the cancer lesion, and the radiation emitted from the brachytherapy source is cancer. It is a treatment method that destroys cancer cells by irradiating the lesion area.

密封小線源療法は、特に前立腺がんの治療に汎用されている。以下、前立腺がんの治療を例にとって、本発明を説明する。  Brachytherapy is widely used especially for the treatment of prostate cancer. Hereinafter, the present invention will be described by taking the treatment of prostate cancer as an example.

放射線を放出する放射線源としては125I又は103Pdが用いられ、これらから放出される特性X線及びγ線が利用される。 125 I or 103 Pd is used as a radiation source for emitting radiation, and characteristic X-rays and γ-rays emitted from these are used.

密封小線源としては、長さ数ミリメートルで直径1ミリメートル程度の円柱形のチタン製のカプセル内に、銀製の短線に化学的に結合された放射線源である125I又は103Pdが密封されたものが用いられる。密封小線源は通常50〜100個程度が、前立腺のがん病巣部分及び/又はがん病巣周辺部分に埋め込まれ、いったん埋め込まれた密封小線源は、原則としてそのまま永久に体内に留め置かれる。後述するように、体内に埋め込まれた密封小線源は、まれに脱落して体内に排出される場合があり、そのような場合、脱落した密封小線源からの放射線を遮蔽する容器に収容する必要がある。このような場合に脱落した密封小線源を収容する容器として、本発明に係る密封小線源収容容器を使用することができる。As a sealed brachytherapy source, 125 I or 103 Pd, which is a radiation source chemically bonded to a silver short wire, was sealed in a cylindrical titanium capsule having a length of several millimeters and a diameter of about 1 millimeter. Things are used. About 50-100 brachytherapy sources are usually implanted in the cancer lesion and / or the surrounding area of the prostate, and the implanted brachytherapy is once permanently retained in the body. It is burned. As will be described later, the sealed brachytherapy source embedded in the body may rarely fall off and be discharged into the body. In such a case, the sealed brachytherapy source is stored in a container that shields radiation from the dropped sealed brachytherapy source. There is a need to. In such a case, the sealed brachytherapy container according to the present invention can be used as a container for housing the sealed brachytherapy source that has dropped out.

本発明の密封小線源収容容器は、容器の全面が放射線の遮蔽材からなり、該遮蔽材の少なくとも一部が亜鉛又は亜鉛合金であるものである。このような構造とすることにより、容器からの放射線の漏洩を防止できる。容器の全面とは、容器の上下面(天井面及び底面)及び側面を含むすべての面を言う。  In the sealed brachytherapy container of the present invention, the entire surface of the container is made of a radiation shielding material, and at least a part of the shielding material is zinc or a zinc alloy. By adopting such a structure, leakage of radiation from the container can be prevented. The whole surface of the container means all surfaces including the upper and lower surfaces (ceiling surface and bottom surface) and side surfaces of the container.

本発明の最大の特徴のひとつは、放射線の遮蔽材の少なくとも一部が亜鉛及び/又は亜鉛合金からなる点に存する。このことにより、遮蔽材として鉛を用いた場合に発生する鉛による環境汚染の問題を軽減又は解消することができるのである。該問題を完全に解消する観点からは、遮蔽材のすべてを亜鉛及び/又は亜鉛合金とすることが好ましい。  One of the greatest features of the present invention resides in that at least a part of the radiation shielding material is made of zinc and / or a zinc alloy. This can reduce or eliminate the problem of environmental pollution caused by lead generated when lead is used as the shielding material. From the viewpoint of completely solving the problem, it is preferable that all of the shielding material is made of zinc and / or a zinc alloy.

亜鉛合金としては、亜鉛以外の金属成分として、アルミニウム2〜6重量%及びマグネシウム0.01〜0.08重量%を含有するものを用いることができる。亜鉛合金を用いることにより、純亜鉛を用いる場合に比べて、容器を製造する際の成形性を向上させることができる。  As a zinc alloy, what contains 2-6 weight% of aluminum and 0.01-0.08 weight% of magnesium as metal components other than zinc can be used. By using a zinc alloy, the moldability at the time of manufacturing a container can be improved compared with the case where pure zinc is used.

本発明の密封小線源収容容器は、上記のとおり、亜鉛及び/又は亜鉛合金を用いることにより鉛による環境汚染を抑制するものであるが、本発明によらず、亜鉛及び/又は亜鉛合金以外の金属を用いた場合には次のとおりの不都合が発生する。すなわち、鉄、ステンレススチール、真鍮、銅等を用いた場合、放射線を十分に遮蔽するためには遮蔽材の厚さを亜鉛に比べて厚くする必要があり、容積及び重量が増加して、取り扱いに不便であると共に、容器の製造時に機械加工を行う必要があり、製造コストが高くなる。また、タングステンを用いた場合、焼結加工が必要であり、製造コストが高くなる。更に錫を用いた場合、錫は高価であると共に、放射線の遮蔽能力に劣る。それに対し、本発明による亜鉛及び/又は亜鉛合金を用いた場合は、鋳物加工が可能であり、製造コストの点で有利である。  As described above, the sealed brachytherapy container of the present invention suppresses environmental pollution due to lead by using zinc and / or a zinc alloy, but is not based on the present invention and other than zinc and / or a zinc alloy. When the above metal is used, the following inconvenience occurs. In other words, when using iron, stainless steel, brass, copper, etc., it is necessary to make the shielding material thicker than zinc in order to sufficiently shield the radiation, and the volume and weight increase, and handling In addition, it is necessary to perform machining at the time of manufacturing the container, which increases the manufacturing cost. Moreover, when tungsten is used, a sintering process is required, which increases the manufacturing cost. Further, when tin is used, tin is expensive and inferior in radiation shielding ability. On the other hand, when the zinc and / or zinc alloy according to the present invention is used, casting can be performed, which is advantageous in terms of manufacturing cost.

次に、本発明の密封小線源収容容器の好ましい実施態様及びその使用方法について説明する。  Next, a preferred embodiment of the sealed brachytherapy container of the present invention and a method for using the same will be described.

本発明の密封小線源収容容器は、プラスチック製の外容器及びプラスチック製の内容器と組み合わせて用いるのが、取り扱いの点から好ましい(図1)。すなわち、外容器内に本発明の密封小線源収容容器を置き、該密封小線源収容容器内に内容器を置き、該内容器内に密封小線源を収納する。外容器及び内容器と本発明の密封小線源収容容器は相対的に移動自由でよく、固着させなくてもよい。外容器及び内容器は、各々その胴の部分と蓋の部分がネジ形式で開放と密閉が可能な構造とする。本発明の密封小線源収容容器も胴の部分と蓋の部分からなるが、胴と蓋は両者が密着する構造であればよく、ネジ形式としなくてもよい。使用時には、内容器の蓋を開放して密封小線源を入れ、内容器の蓋をネジで閉める。該内容器を本発明の密封小線源収容容器の胴の部分に入れ、蓋をする。該密封小線源収容容器を外容器の胴の部分に置き、蓋をネジで閉める。このとき、密封小線源収容容器の蓋の上面と外容器の蓋の下面が接する構造としておくことにより、外容器の蓋をネジ締めすることにより密封小線源収容容器の蓋が密封小線源収容容器の胴に圧着されて密閉される。  It is preferable from the viewpoint of handling that the sealed brachytherapy container of the present invention is used in combination with an outer container made of plastic and an inner container made of plastic (FIG. 1). That is, the sealed brachytherapy source container of the present invention is placed in the outer container, the inner container is placed in the sealed braid source containing container, and the sealed braid source is housed in the inner container. The outer container and the inner container and the sealed brachytherapy container of the present invention may be relatively movable and may not be fixed. Each of the outer container and the inner container has a structure in which the body portion and the lid portion can be opened and closed in a screw form. The sealed brachytherapy container of the present invention is also composed of a barrel portion and a lid portion, but the barrel and the lid may be any structure as long as they are in close contact with each other, and may not be a screw type. At the time of use, the lid of the inner container is opened, a sealed brachytherapy source is inserted, and the lid of the inner container is closed with a screw. The inner container is placed in the barrel portion of the sealed brachytherapy container of the present invention and covered. The sealed brachytherapy container is placed on the barrel of the outer container, and the lid is closed with a screw. At this time, the upper surface of the lid of the sealed brachytherapy source container and the lower surface of the lid of the outer container are in contact with each other. It is crimped and sealed to the barrel of the source container.

本発明の密封小線源収容容器の大きさ及び形状は、要するに密封小線源を収容できればよいのであるが、たとえば、直径30〜40mm、高さ30〜40mmの円筒状のもの又は直径10〜20mm程度、長さ50〜150mm程度の長円筒状のものをあげることができる。密封小線源収容容器は胴体の部分と蓋の部分からなり、両者は密着可能な構造とする。ここで、密着可能な構造であればよく、必ずしもネジ構造等で密閉する必要はない。遮蔽材の厚さは1〜5mmであることが好ましい。該厚さが薄すぎると放射線の遮蔽能力が不十分になる場合があり、一方該厚さが厚すぎると重くなって取り扱いに不便であり、材料コストの点からも不都合である。  The size and shape of the sealed brachytherapy container according to the present invention need only be able to accommodate the sealed brachytherapy source. For example, the cylindrical braid having a diameter of 30 to 40 mm and a height of 30 to 40 mm or a diameter of 10 to 10 A long cylindrical shape having a length of about 20 mm and a length of about 50 to 150 mm can be given. The sealed brachytherapy container is composed of a body portion and a lid portion, and both can be in close contact with each other. Here, the structure may be any structure that can be in close contact, and need not be sealed with a screw structure or the like. The thickness of the shielding material is preferably 1 to 5 mm. If the thickness is too thin, the radiation shielding ability may be insufficient. On the other hand, if the thickness is too thick, it becomes heavy and inconvenient to handle, which is also disadvantageous in terms of material cost.

外容器及び内容器の構造及び大きさは、上記の使用方法に適すればよく、制限はない。なお、プラスチックとしては、たとえばポリプロピレンをあげることができる。  The structure and size of the outer container and the inner container are not limited as long as they are suitable for the above usage. In addition, as a plastic, a polypropylene can be mention | raise | lifted, for example.

本発明の密封小線源収容容器は、前立腺がんの治療用の密封小線源を収容する目的に最適に使用される。ここで、前立腺がんの治療用の密封小線源としては、前立腺がんの治療のために人体に挿入される前のものであってもよい。ところで、前立腺がんの治療用の密封小線源は、前立腺のがん病巣部分及び/又はがん病巣周辺部分に埋め込まれ、いったん埋め込まれた密封小線源は、原則としてそのまま永久に体内に留め置かれるのであるが、体内に埋め込まれた密封小線源が尿と共に人体から外に排泄される場合があり、この排泄された密封小線源は「脱落線源」と呼ばれることがある。脱落線源は回収され、施術を受けた医療施設へ返還される。本発明の密封小線源収容容器は、医療施設に脱落線源を返還する際の脱落線源の一時保管容器としても最適に使用される。  The sealed brachytherapy container of the present invention is optimally used for the purpose of housing a sealed brachytherapy source for the treatment of prostate cancer. Here, the brachytherapy source for prostate cancer treatment may be the one before being inserted into the human body for the treatment of prostate cancer. By the way, the brachytherapy source for treating prostate cancer is implanted in the cancer lesion part of the prostate and / or the peripheral part of the cancer lesion. Although retained, the brachytherapy source implanted in the body may be excreted out of the human body along with urine, and this excreted brachytherapy source may be referred to as a “decline”. The declining line source is collected and returned to the medical facility where the procedure was performed. The sealed brachytherapy container of the present invention is also optimally used as a temporary storage container for a dropout source when returning the dropout source to a medical facility.

本発明の密封小線源収容容器を製造する方法には、制限はなく、亜鉛又は亜鉛合金を加工する通常の鋳物加工法を適用することができる。  There is no restriction | limiting in the method of manufacturing the sealed braid source container of this invention, The normal casting processing method which processes zinc or a zinc alloy can be applied.

次に、本発明を実施例により説明する。  Next, an example explains the present invention.

実施例1、参考例1
密封小線源収容容器として、図2に示す構造ものを用いた。すなわち、容器の上下面の厚さが4mm、側面が厚さ2mmの亜鉛合金(アルミニウム3.5〜4.3重量%、マグネシウム0.02〜0.06重量%、残り亜鉛)からなり、直径36mm、高さ32mmの円筒状のものであり、蓋の部分は胴の部分と印籠じゃくりに形成されている。密封小線源としては、長さ4.6mm、直径0.8mmの円柱形のチタン製のカプセル内に、銀製の短線に化学的に結合された125Iが密封されたものを用いた。1個10MBqの密封小線源5個をプラスチック製の内容器(ポリプロピレン製、厚さ1mm、直径30mm、高さ20mmの上蓋付円筒状)に入れ、該内容器を前記の密封小線源収容容器に入れ、更にプラスチック製の外容器(ポリプロピレン製、厚さ1mm、直径40mm、高さ36mmの上蓋付円筒状)に収納して、漏洩放射線量の測定に供した。測定地点は、密封小線源収容容器の上面、側面及び底面の各面に対し、密着した地点及び1m離れた地点で行った。漏洩放射線量の測定は、電離箱測定器(INOVISION社製451B−DE−S1)で行った。
また、参考例1として、遮蔽材が鉛である容器を用いたこと以外は実施例1と同様に行った。
測定結果を表1に示した。この表から明らかなように、実施例1、参考例1共に、全ての測定地点において、漏洩放射線は検出されなかった。この結果から、本発明による亜鉛合金を遮蔽材とする密封小線源収容容器は、鉛を遮蔽材とする密封小線源収容容器と同等の漏洩放射線遮蔽効果を有することがわかる。
Example 1, Reference Example 1
As the sealed braid source container, the one shown in FIG. 2 was used. That is, it is made of a zinc alloy (aluminum 3.5 to 4.3 wt%, magnesium 0.02 to 0.06 wt%, remaining zinc) having a thickness of 4 mm on the upper and lower surfaces of the container and a thickness of 2 mm on the side surface. It has a cylindrical shape with a height of 36 mm and a height of 32 mm, and the lid portion is formed in the barrel portion and the seal stamp. As the sealed wire source, a cylindrical titanium capsule having a length of 4.6 mm and a diameter of 0.8 mm sealed with 125 I chemically bonded to a silver short wire was used. 5 sealed small wire sources of 10 MBq each are placed in a plastic inner container (made of polypropylene, thickness 1 mm, diameter 30 mm, height 20 mm cylindrical with an upper lid), and the inner container is accommodated in the sealed small beam source. It was put in a container and further housed in a plastic outer container (made of polypropylene, thickness 1 mm, diameter 40 mm, height 36 mm with an upper lid), and used for measurement of leakage radiation dose. The measurement point was performed at a point that was in close contact with each of the top surface, the side surface, and the bottom surface of the sealed brachytherapy container, and a point that was 1 m away. The radiation dose was measured with an ionization chamber measuring instrument (451B-DE-S1 manufactured by INOVISION).
Moreover, it carried out similarly to Example 1 except having used the container whose shielding material is lead as the reference example 1. FIG.
The measurement results are shown in Table 1. As is apparent from this table, no leakage radiation was detected at all measurement points in both Example 1 and Reference Example 1. From this result, it can be seen that the sealed brachytherapy container using the zinc alloy as a shielding material according to the present invention has the same leakage radiation shielding effect as the sealed brachytherapy container containing lead as a shielding material.

Figure 0005653291
・表中の数値は各地点の測定値からバックグラウンド値を引いた値(単位 μSv/h)である。
・密封小線源収容容器の上蓋を開放した場合の容器上部表面(密着)での測定値は320μSv/hであった。
Figure 0005653291
・ The numerical values in the table are values (unit μSv / h) obtained by subtracting the background value from the measured values at each point.
-The measured value on the upper surface (close contact) of the container when the upper lid of the sealed brachytherapy container was opened was 320 μSv / h.

実施例2
放射線源が125Iである場合の測定結果をもとにして、放射線源が103Pdである場合の容器表面線量率をシミュレーションにより求めた。なお、シミュレーションに使用した計算コードは高エネルギー加速器研究機構から公開されている、電子・光子モンテカルロ法シミュレーションコード EGS5 (H.Hirayama,Y.Namito,A.F.Bielajew,S.J.Wilderman and W.R.Nelson:The EGS5 Code System.SLAC−R−730 and KEK Report 2005−8:2005)を用いた。
シミュレーションの結果を図3に示した。図3から、亜鉛合金を遮蔽材とする本発明の密封小線源収容容器は、放射線源が125Iである場合と同様、放射線源が103Pdである場合にも十分な漏洩放射線遮蔽効果を有することがわかる。
Example 2
Based on the measurement result when the radiation source was 125 I, the container surface dose rate when the radiation source was 103 Pd was obtained by simulation. The calculation code used for the simulation is an electron / photon Monte Carlo simulation code EGS5 (H. Hirayama, Y. Namito, A. F. Bielajew, SJ. R. Nelson: The EGS5 Code System, SLAC-R-730 and KEK Report 2005-8: 2005).
The result of the simulation is shown in FIG. From FIG. 3, the sealed brachytherapy container of the present invention using a zinc alloy as a shielding material has a sufficient leakage radiation shielding effect when the radiation source is 103 Pd as well as when the radiation source is 125 I. You can see that

本発明は、125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器であって、容器外への放射線の漏洩を防止し、かつ鉛に起因する環境汚染問題を軽減又は解消でき、しかも製造時の加工性に優れるという特徴を有する密封小線源収容容器を提供することができる。The present invention is a container for containing a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source, preventing leakage of radiation to the outside of the container, and an environment caused by lead It is possible to provide a sealed brachytherapy container that can reduce or eliminate the contamination problem and has excellent characteristics of processability during production.

1 密封小線源
2 内容器(胴)(プラスチック)
3 内容器(蓋)(プラスチック)
4 密封小線源収容容器(胴)(亜鉛合金)
5 密封小線源収容容器(蓋)(亜鉛合金)
6 外容器(胴)(プラスチック)
7 外容器(蓋)(プラスチック)
1 Sealed beam source 2 Inner container (body) (plastic)
3 Inner container (lid) (plastic)
4 Sealed small beam source container (body) (zinc alloy)
5 Sealed beam source container (lid) (zinc alloy)
6 Outer container (body) (plastic)
7 Outer container (lid) (plastic)

Claims (5)

125I又は103Pdを放射線源とする密封小線源療法用の密封小線源を収容する容器であって、
前記密封小線源を収容する内容器と、
第一の開口を有する第一の胴部と、前記第一の開口を覆う第一の蓋部とを備え、前記内容器を前記第一の胴部に収容する密封小線源収容容器と、
第二の開口を有する第二の胴部と、前記第二の開口を覆う蓋部とを備え、前記密封小線源収容容器を前記第二の胴部に収容する外容器と、
を有し、
前記密封小線源収容容器の全面が放射線の遮蔽材からなり、前記遮蔽材の少なくとも一部が亜鉛及び/又は亜鉛合金であり、
前記第二の蓋部と前記第二の胴部とがネジ形式で密着することにより、前記第二の開口が前記第二の蓋部で覆われ、
前記第一の蓋部が前記第一の開口を覆い、前記第二の蓋部が前記第二の開口を覆うとき、前記第一の蓋部の上面と、前記第二の蓋部の下面とが接する構造を備える、容器。
A container containing a brachytherapy source for brachytherapy using 125 I or 103 Pd as a radiation source,
An inner container that houses the sealed braid source;
A sealed brachytherapy container containing a first trunk having a first opening and a first lid covering the first opening, and housing the inner container in the first trunk;
An outer container that includes a second body having a second opening and a lid that covers the second opening, and that accommodates the sealed brachytherapy source container in the second body;
Have
The entire surface of the sealed brachytherapy container is made of a radiation shielding material, and at least a part of the shielding material is zinc and / or a zinc alloy,
The second opening is covered with the second lid part by closely contacting the second lid part and the second body part in a screw form,
When the first lid covers the first opening and the second lid covers the second opening, the upper surface of the first lid and the lower surface of the second lid A container having a structure in contact with.
前記遮蔽材のすべてが亜鉛及び/又は亜鉛合金である請求項1記載の容器。 The container according to claim 1, wherein all of the shielding material is zinc and / or a zinc alloy. 前記密封小線源が、前立腺がんの治療用のものである請求項1又は2に記載の容器。 The container according to claim 1 or 2, wherein the brachytherapy source is for treating prostate cancer. 前記密封小線源が、前立腺がんの治療のために人体に挿入される前のものである請求項3記載の容器。 The container according to claim 3, wherein the brachytherapy source is before being inserted into a human body for the treatment of prostate cancer. 前記密封小線源が、前立腺がんの治療のために人体に挿入された後、人体から脱落したものである請求項3記載の容器。
The container according to claim 3, wherein the sealed brachytherapy source is dropped from the human body after being inserted into the human body for the treatment of prostate cancer.
JP2011108769A 2011-04-22 2011-04-22 Sealed brachytherapy container Expired - Fee Related JP5653291B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011108769A JP5653291B2 (en) 2011-04-22 2011-04-22 Sealed brachytherapy container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011108769A JP5653291B2 (en) 2011-04-22 2011-04-22 Sealed brachytherapy container

Publications (2)

Publication Number Publication Date
JP2012230093A JP2012230093A (en) 2012-11-22
JP5653291B2 true JP5653291B2 (en) 2015-01-14

Family

ID=47431738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011108769A Expired - Fee Related JP5653291B2 (en) 2011-04-22 2011-04-22 Sealed brachytherapy container

Country Status (1)

Country Link
JP (1) JP5653291B2 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195335B (en) * 1984-11-05 1988-04-28 Peter Teleki Method and modifying body for influencing effect on a target sensitive to radiation exerted by x-ray or gamma radiation
JPS63117286A (en) * 1986-11-04 1988-05-21 Matsushita Electric Ind Co Ltd Radiation detector
JP3630772B2 (en) * 1994-07-15 2005-03-23 株式会社日本触媒 Transport container for radioactive drug solution enclosure
GB2364379B (en) * 1997-08-11 2002-03-13 Siemens Plc Personal radiation dosemeter with electromagnetic and radiological screening
JP2002277588A (en) * 2001-03-09 2002-09-25 Schering Ag Packaging case for radioactive material and radioactive solution injection cylinder
JP2004028789A (en) * 2002-06-26 2004-01-29 Toshiba Corp Radiation shield, radiation detector, and radiation diagnostic device
JP4469189B2 (en) * 2004-02-12 2010-05-26 日本メジフィジックス株式会社 Radiopharmaceutical transport container
US7425195B2 (en) * 2004-08-13 2008-09-16 Core Oncology, Inc. Radiation shielding device
EP1899982B1 (en) * 2005-05-16 2009-07-08 Mallinckrodt, Inc. Radiopharmaceutical container having syringe capper
EP1933329A3 (en) * 2005-07-27 2009-12-16 Mallinckrodt, Inc. Radiation-shielding assemblies and methods of using the same
WO2007070871A1 (en) * 2005-12-15 2007-06-21 Medi-Physics, Inc. Seed-cartridge barrel assembler

Also Published As

Publication number Publication date
JP2012230093A (en) 2012-11-22

Similar Documents

Publication Publication Date Title
EP2544188A3 (en) Radiation-shielding assemblies and methods of using the same
KR20130139918A (en) Collimator and ct equipment comprising the same
Oliveira et al. What do we know about the α/β for prostate cancer?
US20130294576A1 (en) Monochromatic x-ray devices and methods of use
Heukelom et al. Wedge factor constituents of high energy photon beams: field size and depth dependence
Taha et al. Monte Carlo simulation of dose enhancement due to silver nanoparticles implantation in brain tumor brachytherapy using a digital phantom
Bernard et al. Dosimetric study of a new polymer encapsulated palladium-103 seed
JP5653291B2 (en) Sealed brachytherapy container
Ballester et al. Study of encapsulated sources for their potential use in brachytherapy
Guo et al. A Functional Stent Encapsulating Radionuclide in Temperature‐Memory Spiral Tubes for Malignant Stenosis of Esophageal Cancer
Granero et al. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169
BAGHANI et al. Monte Carlo determination of dosimetric parameters of a new 125I brachytherapy source according to AAPM TG-43 (U1) protocol
RU139320U1 (en) CONTAINER FOR RADIOACTIVE MATERIAL (MATERIAL)
Pearce et al. The characterization of the Advanced Markus ionization chamber for use in reference electron dosimetry in the UK
Beyzadeoglu et al. Evaluation of scatter dose of dental titanium implants exposed to photon beams of different energies and irradiation angles in head and neck radiotherapy
Chen et al. Dose rate constant of a cesium‐131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma‐ray spectrometry
Reynoso et al. Design of an Yb‐169 source optimized for gold nanoparticle‐aided radiation therapy
Saxena et al. Development of a new design 125I-brachytherapy seed for its application in the treatment of eye and prostate cancer
Pejović-Milić et al. Development of an irradiation/shielding cavity for in vivo neutron activation analysis of manganese in human bone
Saxena et al. Development of a 125I source for its application in bone densitometry
Ravichandran et al. Testicular shield for para-aortic radiotherapy and estimation of gonad doses
RU2621666C1 (en) Closed source of ionizing radiation and method of preparing it for use
Hosseini et al. Dosimetric comparison of four new design brachytherapy sources: Optimal design using silver and copper rod cores
Schaart et al. The radial depth–dose distribution of a 188W/188Re β line source measured with novel, ultra-thin TLDs in a PMMA phantom: comparison with Monte Carlo simulations
Abboud et al. Experimental and theoretical dosimetry of a new polymer encapsulated iodine‐125 source—SmartSeed: Dosimetric impact of fluorescence x rays

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130424

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20130524

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140417

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140626

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141111

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141118

R150 Certificate of patent or registration of utility model

Ref document number: 5653291

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees